WITHDRAWN: Primary prophylaxis in haemophilia care: Guideline update 2016
- 1 February 2020
- journal article
- withdrawal
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 80, 102172
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council (K2013-64X-22298-01-3)
- Lund University
This publication has 39 references indexed in Scilit:
- Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970sBlood, 2013
- Short‐term low‐dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi‐centre pilot study in ChinaHaemophilia, 2012
- Guidelines for the management of hemophiliaHaemophilia, 2012
- A United Kingdom Haemophilia Centre Doctors’ Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia ABritish Journal of Haematology, 2010
- Comparative pharmacokinetics of plasma‐ and albumin‐free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age‐related differences and implications for dose tailoringJournal of Thrombosis and Haemostasis, 2010
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Variability in clinical phenotype of severe haemophilia: the role of the first joint bleedHaemophilia, 2005
- Can long‐term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the NetherlandsBritish Journal of Haematology, 2005
- Pharmacokinetic dosing in prophylactic treatment of hemophilia AEuropean Journal of Haematology, 1993
- RADIOLOGIC EVALUATION OF PROPHYLAXIS IN SEVERE HAEMOPHILIAActa Paediatrica, 1981